Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

India agrees 'significantly lower' AstraZeneca vaccine price

FILE PHOTO: A healthcare worker holding a rose receives an AstraZeneca's COVISHIELD vaccine, during the coronavirus disease (COVID-19) vaccination campaign, at a medical centre in Mumbai, India, January 16, 2021. REUTERS/Francis Mascarenhas

The Indian government has lowered the price at which it buys AstraZeneca's COVID-19 vaccine doses being produced by the Serum Institute of India (SII), the federal health secretary said on Thursday.

"The renegotiated price is significantly lower than 200 rupees ($2.75) per dose," Health Secretary Rajesh Bhushan told a news conference.

The SII, the world's biggest vaccine maker, has licensed the vaccine from AstraZeneca and Oxford University and markets it as COVISHIELD.

(Reporting by Neha Arora in New Delhi and Sachin Ravikumar in Bengaluru; editing by Jason Neely)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.